Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/26/2870438/0/en/CG-Oncology-to-Host-Virtual-Investor-Event-on-Friday-May-3-2024.html
https://www.globenewswire.com/news-release/2024/04/24/2868754/0/en/CG-Oncology-to-Unveil-Encouraging-Results-on-Cretostimogene-in-Combination-with-Pembrolizumab-at-ASCO-2024.html
https://www.globenewswire.com/news-release/2024/03/28/2853920/0/en/CG-Oncology-to-Present-Results-on-Cretostimogene-at-the-AUA-2024-Annual-Meeting.html
https://www.globenewswire.com//news-release/2024/02/27/2835948/0/en/CG-Oncology-Announces-First-Patient-Dosed-in-PIVOT-006-Phase-3-Clinical-Trial-of-Cretostimogene-in-Intermediate-risk-Non-Muscle-Invasive-Bladder-Cancer.html
https://www.fiercebiotech.com/biotech/first-biotech-ipo-year-cg-oncology-overshoots-estimates-bringing-380m
https://endpts.com/cg-oncology-kickstarts-2024-biotech-ipo-class-with-380m-listing/
https://www.fiercebiotech.com/biotech/cg-oncology-aims-209m-ipo-more-biotechs-eye-path-public-markets
https://www.fiercebiotech.com/biotech/cg-oncology-plans-ipo-ahead-phase-3-bladder-cancer-drug-readout